The pioneer of anticancer drugs: cisplatin
The compound cis-[Pt(NH3)2Cl2] was first described by Italian chemist Michele Peyrone in 1845, and known for a long time as Peyrone's salt. The structure was deduced by Alfred Werner in 1893. In 1965, Barnett Rosenberg, Van Camp et al. of Michigan State University discovered that electrolysis of platinum electrodes generated a soluble platinum complex which inhibited binary fission in Escherichia coli (E. coli) bacteria. Although bacterial cell growth continued, cell division … Webb9 mars 2024 · The dysregulation of apoptosis and DNA damage repair are two leading …
The pioneer of anticancer drugs: cisplatin
Did you know?
Webb1 jan. 2024 · Cisplatin was absorbed more readily than carboplatin, both in vitro and in … Webb1 juli 2024 · Abstract. Cisplatin or (SP-4-2)-diamminedichloridoplatinum (II) is one of the most potential and widely used drugs for the treatment of various solid cancers such as testicular, ovarian, head and neck, bladder, lung, cervical cancer, melanoma, lymphomas and several others. Cisplatin exerts anticancer activity via multiple mechanisms but its ...
WebbEver since the initial discovery of the anticancer activity of cisplatin, major efforts have been devoted to elucidate the biochemical mechanisms of antitumor activity of cisplatin in order to be able to rationally design novel platinum based drugs with superior pharmacological profiles. WebbCisplatin, cis-diamminedichlorido-platinum(II), is an important therapeutic tool in the …
Webbför 2 dagar sedan · One of the main problems in chemotherapy using platinum drugs as … WebbAbstract: This review provides a brief view of the cisplatin's mechanism of action, toxicity …
WebbKey Points. Cisplatin, a chemotherapy drug, is best known for curing testicular cancer.; Prior to the discovery of cisplatin, men with testicular cancer had few medical options. Cisplatin is also used in the treatment …
WebbAmong the platinum-based anticancer drugs, Cisplatin (cis-diamine dichloroplatinum (II), cis- [Pt (NH3)2Cl2]) is one of the most potent components of cancer chemotherapy. The nephrotoxicity, neurotoxicity and ototoxicity, and platinum compounds associated resistant cancer are some major disadvantages. flagship credit acceptance ceoWebb15 juni 2010 · Uptake of the anticancer drug cisplatin is mediated by the copper transporter CTR1 in cultured cells. Here we show in human ovarian tumors that low levels of Ctr1 mRNA are associated with poor clinical response to platinum-based therapy. Using a mouse model of human cervical cancer, we demonstrate t … canon imageprograf pf-05 printheadWebbCisplatin is approved to be used alone or with other drugs to treat: Bladder cancer. It is … flagship credit acceptance auto payoffWebbIn this work, two thiourea ligands bearing a phosphine group in one arm and in the other a phenyl group (T2) or 3,5-di-CF3 substituted phenyl ring (T1) have been prepared and their coordination to Au and Ag has been studied. A different behavior is observed for gold complexes, a linear geometry with coordination only to the phosphorus atom or an … flagship construction scWebbFollowing its approval as second-line monotherapy for locally advanced or metastatic non-squamous NSCLC, pemetrexed has established itself as the first-line regimen in combination with cisplatin, and its powerful antitumor effects and less cumulative toxicities were then taken advantage of in the JMEN and PARAMOUNT trials, … flagship credit acceptance collectionsWebbSummary. Cisplatin Chemistry and Biochemistry of a Leading Anticancer Drug Since … flagship credit acceptance contactWebbThe rediscovery of platinum-based cancer therapy Platinum (Pt) compounds entered the … flagship credit acceptance bbb